chr5-10258400-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_012073.5(CCT5):​c.738G>A​(p.Ala246Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0324 in 1,614,096 control chromosomes in the GnomAD database, including 1,000 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A246A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.027 ( 73 hom., cov: 33)
Exomes 𝑓: 0.033 ( 927 hom. )

Consequence

CCT5
NM_012073.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.23

Publications

6 publications found
Variant links:
Genes affected
CCT5 (HGNC:1618): (chaperonin containing TCP1 subunit 5) The protein encoded by this gene is a molecular chaperone that is a member of the chaperonin containing TCP1 complex (CCT), also known as the TCP1 ring complex (TRiC). This complex consists of two identical stacked rings, each containing eight different proteins. Unfolded polypeptides enter the central cavity of the complex and are folded in an ATP-dependent manner. The complex folds various proteins, including actin and tubulin. Mutations in this gene cause hereditary sensory and autonomic neuropathy with spastic paraplegia (HSNSP). Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 5 and 13. [provided by RefSeq, Apr 2015]
CCT5 Gene-Disease associations (from GenCC):
  • hereditary sensory and autonomic neuropathy with spastic paraplegia
    Inheritance: AR, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 5-10258400-G-A is Benign according to our data. Variant chr5-10258400-G-A is described in ClinVar as Benign. ClinVar VariationId is 240841.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.23 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0275 (4187/152276) while in subpopulation NFE AF = 0.0399 (2716/68032). AF 95% confidence interval is 0.0387. There are 73 homozygotes in GnomAd4. There are 2080 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 73 AR,AD,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCT5NM_012073.5 linkc.738G>A p.Ala246Ala synonymous_variant Exon 6 of 11 ENST00000280326.9 NP_036205.1 P48643-1V9HW37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCT5ENST00000280326.9 linkc.738G>A p.Ala246Ala synonymous_variant Exon 6 of 11 1 NM_012073.5 ENSP00000280326.4 P48643-1

Frequencies

GnomAD3 genomes
AF:
0.0275
AC:
4186
AN:
152158
Hom.:
73
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00579
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.0200
Gnomad ASJ
AF:
0.0452
Gnomad EAS
AF:
0.00307
Gnomad SAS
AF:
0.00995
Gnomad FIN
AF:
0.0592
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0399
Gnomad OTH
AF:
0.0248
GnomAD2 exomes
AF:
0.0273
AC:
6866
AN:
251472
AF XY:
0.0276
show subpopulations
Gnomad AFR exome
AF:
0.00449
Gnomad AMR exome
AF:
0.0156
Gnomad ASJ exome
AF:
0.0397
Gnomad EAS exome
AF:
0.00391
Gnomad FIN exome
AF:
0.0541
Gnomad NFE exome
AF:
0.0355
Gnomad OTH exome
AF:
0.0306
GnomAD4 exome
AF:
0.0329
AC:
48047
AN:
1461820
Hom.:
927
Cov.:
33
AF XY:
0.0325
AC XY:
23660
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.00430
AC:
144
AN:
33480
American (AMR)
AF:
0.0161
AC:
721
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0382
AC:
998
AN:
26136
East Asian (EAS)
AF:
0.00169
AC:
67
AN:
39700
South Asian (SAS)
AF:
0.0126
AC:
1091
AN:
86256
European-Finnish (FIN)
AF:
0.0555
AC:
2967
AN:
53418
Middle Eastern (MID)
AF:
0.00728
AC:
42
AN:
5768
European-Non Finnish (NFE)
AF:
0.0362
AC:
40202
AN:
1111942
Other (OTH)
AF:
0.0301
AC:
1815
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
2785
5569
8354
11138
13923
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1426
2852
4278
5704
7130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0275
AC:
4187
AN:
152276
Hom.:
73
Cov.:
33
AF XY:
0.0279
AC XY:
2080
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.00578
AC:
240
AN:
41546
American (AMR)
AF:
0.0201
AC:
307
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0452
AC:
157
AN:
3472
East Asian (EAS)
AF:
0.00308
AC:
16
AN:
5194
South Asian (SAS)
AF:
0.0102
AC:
49
AN:
4818
European-Finnish (FIN)
AF:
0.0592
AC:
627
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0399
AC:
2716
AN:
68032
Other (OTH)
AF:
0.0246
AC:
52
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
222
444
666
888
1110
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0303
Hom.:
43
Bravo
AF:
0.0229
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.0327
EpiControl
AF:
0.0333

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary sensory and autonomic neuropathy with spastic paraplegia Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
3.6
DANN
Benign
0.55
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11557649; hg19: chr5-10258512; API